XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.25.2

Shareholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2025
Stockholders' Equity Note [Abstract] |
Shareholders' Equity | Shareholders’ Equity The following table presents the amounts related to each component of OCI:
| Three Months Ended June 30,
| 2025 |  | 2024
| Pretax |  | Income Tax Benefit (Expense) |  | Net of Tax |  | Pretax |  | Income Tax Benefit (Expense) |  | Net of Tax
| (in millions)
Net unrealized gains (losses) on securities: |  |  |  |  |  |  |  |  |  |  |
Net unrealized gains (losses) on securities arising during the period (1) | $ | 233 |  |  | $ | (54) |  |  | $ | 179 |  |  | $ | (180) |  |  | $ | 38 |  |  | $ | (142) |
Reclassification of net (gains) losses on securities included in net income (2) | 15 |  |  | (3) |  |  | 12 |  |  | 2 |  |  | — |  |  | 2 |
Impact of benefit reserves and reinsurance recoverables | 2 |  |  | (1) |  |  | 1 |  |  | 6 |  |  | (1) |  |  | 5 |
Net unrealized gains (losses) on securities | 250 |  |  | (58) |  |  | 192 |  |  | (172) |  |  | 37 |  |  | (135) |
Net unrealized gains (losses) on derivatives: |  |  |  |  |  |  |  |  |  |  |
Net unrealized gains (losses) on derivatives arising during the period | (1) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |
Net unrealized gains (losses) on derivatives | (1) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |
Effect of changes in discount rate assumptions on certain long-duration contracts | (15) |  |  | 3 |  |  | (12) |  |  | 79 |  |  | (17) |  |  | 62 |
Effect of changes in instrument-specific credit risk on MRBs | 1 |  |  | — |  |  | 1 |  |  | 13 |  |  | (4) |  |  | 9 |
Foreign currency translation | 107 |  |  | (4) |  |  | 103 |  |  | 2 |  |  | (1) |  |  | 1 |
Total other comprehensive income (loss) | $ | 342 |  |  | $ | (59) |  |  | $ | 283 |  |  | $ | (78) |  |  | $ | 15 |  |  | $ | (63) |
| Six Months Ended June 30,
| 2025 |  | 2024
| Pretax |  | Income Tax Benefit (Expense) |  | Net of Tax |  | Pretax |  | Income Tax Benefit (Expense) |  | Net of Tax
| (in millions)
Net unrealized gains (losses) on securities: |  |  |  |  |  |  |  |  |  |  |
Net unrealized gains (losses) on securities arising during the period (1) | $ | 724 |  |  | $ | (164) |  |  | $ | 560 |  |  | $ | (416) |  |  | $ | 90 |  |  | $ | (326) |
Reclassification of net (gains) losses on securities included in net income (2) | 10 |  |  | (2) |  |  | 8 |  |  | 2 |  |  | — |  |  | 2 |
Impact of benefit reserves and reinsurance recoverables | (2) |  |  | — |  |  | (2) |  |  | 14 |  |  | (3) |  |  | 11 |
Net unrealized gains (losses) on securities | 732 |  |  | (166) |  |  | 566 |  |  | (400) |  |  | 87 |  |  | (313) |
Net unrealized gains (losses) on derivatives: |  |  |  |  |  |  |  |  |  |  |
Net unrealized gains (losses) on derivatives arising during the period | (11) |  |  | 2 |  |  | (9) |  |  | — |  |  | — |  |  | — |
Net unrealized gains (losses) on derivatives | (11) |  |  | 2 |  |  | (9) |  |  | — |  |  | — |  |  | — |
Effect of changes in discount rate assumptions on certain long-duration contracts | (53) |  |  | 11 |  |  | (42) |  |  | 167 |  |  | (36) |  |  | 131 |
Effect of changes in instrument-specific credit risk on MRBs | 2 |  |  | — |  |  | 2 |  |  | (35) |  |  | 7 |  |  | (28) |
Foreign currency translation | 159 |  |  | (4) |  |  | 155 |  |  | (16) |  |  | (1) |  |  | (17) |
Total other comprehensive income (loss) | $ | 829 |  |  | $ | (157) |  |  | $ | 672 |  |  | $ | (284) |  |  | $ | 57 |  |  | $ | (227) |
(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period. (2) Reclassification amounts are recorded in Net investment income. Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates. The following table presents the changes in the balances of each component of AOCI, net of tax:
| Net Unrealized Gains (Losses) on Securities |  | Net Unrealized Gains (Losses) on Derivatives |  | Effect of Changes in Discount Rate Assumptions on Certain Long-Duration Contracts |  | Effect of Changes in Instrument-Specific Credit Risk on MRBs |  | Defined Benefit Plans |  | Foreign Currency Translation |  | Other |  | Total
| (in millions)
Balance at April 1, 2025 | $ | (1,078) |  | $ | (3) |  | $ | (3) |  | $ | (146) |  | $ | (45) |  | $ | (243) |  | $ | (1) |  | $ | (1,519)
OCI before reclassifications | 180 |  | (1) |  | (12) |  | 1 |  | — |  | 103 |  | — |  | 271
Amounts reclassified from AOCI | 12 |  | — |  | — |  | — |  | — |  | — |  | — |  | 12
Total OCI | 192 |  | (1) |  | (12) |  | 1 |  | — |  | 103 |  | — |  | 283
Balance at June 30, 2025 | $ | (886) |  | $ | (4) |  | $ | (15) |  | $ | (145) |  | $ | (45) |  | $ | (140) |  | $ | (1) |  | $ | (1,236)
Balance at April 1, 2024 | $ | (1,419) |  | $ | 5 |  | $ | (57) |  | $ | (122) |  | $ | (60) |  | $ | (276) |  | $ | (1) |  | $ | (1,930)
OCI before reclassifications | (137) |  | — |  | 62 |  | 9 |  | — |  | 1 |  | — |  | (65)
Amounts reclassified from AOCI | 2 |  | — |  | — |  | — |  | — |  | — |  | — |  | 2
Total OCI | (135) |  | — |  | 62 |  | 9 |  | — |  | 1 |  | — |  | (63)
Balance at June 30, 2024 | $ | (1,554) |  | $ | 5 |  | $ | 5 |  | $ | (113) |  | $ | (60) |  | $ | (275) |  | $ | (1) |  | $ | (1,993)
Balance at January 1, 2025 | $ | (1,452) |  | $ | 5 |  | $ | 27 |  | $ | (147) |  | $ | (45) |  | $ | (295) |  | $ | (1) |  | $ | (1,908)
OCI before reclassifications | 558 |  | (9) |  | (42) |  | 2 |  | — |  | 155 |  | — |  | 664
Amounts reclassified from AOCI | 8 |  | — |  | — |  | — |  | — |  | — |  | — |  | 8
Total OCI | 566 |  | (9) |  | (42) |  | 2 |  | — |  | 155 |  | — |  | 672
Balance at June 30, 2025 | $ | (886) |  | $ | (4) |  | $ | (15) |  | $ | (145) |  | $ | (45) |  | $ | (140) |  | $ | (1) |  | $ | (1,236)
Balance at January 1, 2024 | $ | (1,241) |  | $ | 5 |  | $ | (126) |  | $ | (85) |  | $ | (60) |  | $ | (258) |  | $ | (1) |  | $ | (1,766)
OCI before reclassifications | (315) |  | — |  | 131 |  | (28) |  | — |  | (17) |  | — |  | (229)
Amounts reclassified from AOCI | 2 |  | — |  | — |  | — |  | — |  | — |  | — |  | 2
Total OCI | (313) |  | — |  | 131 |  | (28) |  | — |  | (17) |  | — |  | (227)
Balance at June 30, 2024 | $ | (1,554) |  | $ | 5 |  | $ | 5 |  | $ | (113) |  | $ | (60) |  | $ | (275) |  | $ | (1) |  | $ | (1,993)
For the six months ended June 30, 2025 and 2024, the Company repurchased a total of 2.3 million shares and 2.5 million shares, respectively, of its common stock for an aggregate cost of $1.2 billion and $1.0 billion, respectively. On July 24, 2023, the Company’s Board of Directors authorized an additional $3.5 billion for the repurchase of the Company’s common stock through September 30, 2025, which was exhausted during the second quarter of 2025. On April 22, 2025, the Company’s Board of Directors authorized an additional $4.5 billion for the repurchase of the Company’s common stock through June 30, 2027. As of June 30, 2025, the Company had $4.2 billion remaining under this share repurchase authorization. The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase. For the six months ended June 30, 2025 and 2024, the Company reacquired 0.2 million and 0.3 million shares, respectively, of its common stock through the surrender of shares upon vesting and paid in the aggregate $123 million and $104 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the six months ended June 30, 2025 and 2024, the Company reacquired 0.1 million shares and 0.3 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $47 million and $119 million, respectively. During the six months ended June 30, 2025 and 2024, the Company reissued 0.6 million and 0.7 million, respectively, treasury shares for restricted stock award grants, performance share units and issuance of shares vested under advisor deferred compensation plans.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration